Product image of Imigran (Sumatriptan) supplied by GNH India

Imigran

Active Ingredient:
Sumatriptan
Origin:
EU

Imigran (Sumatriptan)

Sumatriptan, the active ingredient in Imigran, is a Triptan (5‑HT1B/1D receptor agonist) presented as an injection for subcutaneous use. The EU‑market product is manufactured under strict quality standards and is indicated for the acute treatment of migraine attacks, with or without aura, in adult patients.

GNH India supplies Imigran as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures reliable access to this medication across multiple regions, adhering to import regulations and cold‑chain requirements where applicable.

Manufacturer / TM Owner

Glaxosmithkline (Ireland) Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Imigran (sumatriptan) is used within the triptan class to treat acute migraine episodes.

  • Migraine with aura: provides rapid relief of headache pain and associated symptoms.
  • Migraine without aura: reduces attack duration and severity when administered early.
  • Acute episodic migraine: aborts attacks and improves functional ability during an episode.

How It Works

  • Sumatriptan selectively activates serotonin 5‑HT1B and 5‑HT1D receptors on cranial blood vessels and trigeminal nerve endings. This activation causes vasoconstriction of dilated intracranial arteries and inhibits the release of pro‑inflammatory neuropeptides, thereby interrupting the migraine cascade and alleviating headache pain.

Side Effects

Common and serious adverse reactions have been reported with sumatriptan injection.

Common Side Effects

  • Injection site pain: mild to moderate discomfort at the injection site.
  • Tingling or numbness: transient paresthesia in the face or extremities.
  • Flushing: warm sensation and reddening of the skin.
  • Chest pressure: mild, non‑cardiac chest discomfort.
  • Nausea: occasional upset stomach.
  • Dizziness: brief light‑headedness.

Serious or Rare Side Effects

  • Coronary vasospasm: constriction of coronary arteries that may cause chest pain.
  • Myocardial infarction: rare heart attack, especially in patients with cardiovascular disease.
  • Severe hypertension: sudden high blood pressure episodes.
  • Serotonin syndrome: potentially life‑threatening condition when combined with other serotonergic agents.
  • Anaphylaxis: severe allergic reaction requiring immediate medical attention.
  • Stroke: rare cerebrovascular event.

Precautions & Warnings

Before prescribing Imigran, clinicians should consider several safety precautions.

  • Cardiovascular disease: avoid use in patients with ischemic heart disease, uncontrolled hypertension, or history of stroke.
  • Hemiplegic or basilar migraine: contraindicated due to risk of cerebrovascular events.
  • Concomitant serotonergic drugs: assess risk of serotonin syndrome when combined with SSRIs, SNRIs, or MAO inhibitors.
  • Pregnancy and lactation: safety not established; use only if potential benefit justifies risk.
  • Age considerations: not recommended for children or adolescents under 18 years.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Sumatriptan may interact with other medicines, requiring avoidance or close monitoring.

Major Interactions (Avoid)

  • MAO inhibitors: combined use can precipitate severe hypertension or serotonin syndrome.
  • Other triptans or ergot derivatives: increase risk of vasospasm and serious cardiovascular events.
  • SSRIs, SNRIs, or other serotonergic agents: heightened potential for serotonin syndrome.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: may increase plasma concentrations of sumatriptan.
  • Antihypertensive agents: monitor blood pressure for additive effects.
  • Oral contraceptives: may slightly elevate risk of cardiovascular side effects.

Frequently Asked Questions

Imigran contains sumatriptan, a triptan medication indicated for the acute treatment of migraine attacks, with or without aura, in adult patients. It is used to relieve headache pain and associated migraine symptoms when taken early in an attack.

Sumatriptan works by selectively stimulating serotonin 5‑HT1B and 5‑HT1D receptors on cranial blood vessels and trigeminal nerve endings. This causes vasoconstriction of dilated intracranial arteries and blocks the release of inflammatory neuropeptides, interrupting the migraine cascade and reducing pain.

The prescribed dose of Imigran is determined by the treating physician based on the patient’s clinical condition and response. Typical subcutaneous formulations are available in fixed strengths, and the prescriber decides the appropriate amount and timing for each migraine episode.

Safety of sumatriptan in pregnancy and lactation has not been definitively established. It should be used only if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made in consultation with a healthcare professional.

To order Imigran, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and necessary import documentation.

Imigran (sumatriptan) belongs to the triptan class, which is generally more effective for moderate to severe migraine attacks than simple analgesics or NSAIDs. Compared with newer CGRP antagonists, triptans act via serotonin receptors and have a well‑established safety profile, but they carry a higher risk of cardiovascular effects.

Imigran should be stored at 2‑8 °C (refrigerated), protected from light, and must not be frozen or shaken. Keep the product in its original packaging until use, and allow it to reach room temperature briefly before administration if required by the label.

Imigran is given as a subcutaneous injection, typically into the outer thigh or abdomen. The injection is performed using a sterile needle, and the dose is administered once per migraine attack. Patients should be instructed on proper injection technique and advised to seek medical help if severe reactions occur.

Serious risks associated with Imigran include coronary vasospasm, myocardial infarction, severe hypertension, serotonin syndrome (especially when combined with other serotonergic drugs), anaphylaxis, and rare cerebrovascular events such as stroke. Immediate medical attention is required if any of these symptoms develop.

Imigran is contraindicated in patients with a history of ischemic heart disease, uncontrolled hypertension, hemiplegic or basilar migraine, severe hepatic impairment, and those currently taking MAO inhibitors or other triptans. It is also not recommended for children or adolescents under 18 years of age.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Sumatriptan

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT